Fayetteville, NY, United States of America

Audrey Bernstein

This inventor holds 1 USPTO granted patent. Top assignee: The State University of New York. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Audrey Bernstein. Retrieved from https://idiyas.com/inventor/audrey-bernstein-mq216bg2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Audrey Bernstein and Her Patent on Targeted siRNA Compositions

Introduction

Audrey Bernstein is an inventor associated with Fayetteville, New York, and The State University of New York. Her work includes a patent concerning self-deliverable small interfering RNA (siRNA) compositions intended to prevent or inhibit fibrosis and scarring.

Latest Patents

Bernstein is credited with 1 patent: “Targeted Self-Deliverable siRNA Compositions and Methods for Preventing or Inhibiting Fibrosis and/or Scarring” (US Patent 10). The invention focuses on targeted siRNA compositions and methods designed to address fibrosis and scarring.

Career Highlights

Bernstein’s listed patent connects her inventive work with research at The State University of New York. The patent’s subject matter reflects an application of RNA-based technology to the prevention or inhibition of tissue fibrosis and scarring.

Collaborations

The provided information identifies Alexey Wolfson and Sean McCauley as Bernstein’s coworkers. Their names are associated with the same research and patent context.

Conclusion

Audrey Bernstein’s patent highlights her contribution to research on targeted siRNA approaches for preventing or inhibiting fibrosis and scarring.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…